Get the Stockscreener App
1.76
0.57%
0.01
After Hours:
1.77
0.01
+0.57%
Cognition Therapeutics Inc stock is traded at $1.76, with a volume of 2.06M.
It is up +0.57% in the last 24 hours and down -26.67% over the past month.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
See More
Previous Close:
$1.75
Open:
$1.78
24h Volume:
2.06M
Relative Volume:
0.20
Market Cap:
$129.40M
Revenue:
-
Net Income/Loss:
$-22.83M
P/E Ratio:
-2.2278
EPS:
-0.79
Net Cash Flow:
$-20.87M
1W Performance:
+16.56%
1M Performance:
-26.67%
6M Performance:
+448.63%
1Y Performance:
+340.00%
1-Day Range:
$1.67
$1.825
1-Week Range:
$1.41
$1.825
52-Week Range:
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
Name
Cognition Therapeutics Inc
Sector
Industry
Phone
412-481-2210
Address
2403 SIDNEY STREET, PITTSBURGH
Compare CGTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
1.76 | 154.39M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Jul-30-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Nov-03-21 | Initiated | B. Riley Securities | Buy |
| Nov-03-21 | Initiated | Oppenheimer | Outperform |
Cognition Therapeutics Inc Stock (CGTX) Latest News
Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade - sharewise.com
Cognition Therapeutics (NASDAQ:CGTX) Stock Price Up 13.6%Still a Buy? - MarketBeat
Will Cognition Therapeutics Inc. benefit from macro trendsMarket Performance Recap & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to Cognition Therapeutics Inc. stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Has Cognition Therapeutics Inc. found a price floor2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Analyzing drawdowns of Cognition Therapeutics Inc. with statistical toolsWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Is it time to cut losses on Cognition Therapeutics Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com
Has Cognition Therapeutics Inc. formed a bullish divergenceQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Does Cognition Therapeutics Inc. stock trade at a discount to peersWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Is Cognition Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Can Cognition Therapeutics Inc. stock hit record highs againEarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Pattern recognition hints at Cognition Therapeutics Inc. upside2025 Institutional Moves & AI Powered Market Trend Analysis - newser.com
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Chart based analysis of Cognition Therapeutics Inc. trends2025 Big Picture & Short-Term High Return Strategies - newser.com
What drives Cognition Therapeutics Inc stock priceStock Split Announcements & Budget Friendly Trading Ideas - earlytimes.in
Published on: 2025-09-29 01:45:20 - newser.com
Cognition Therapeutics (NASDAQ:CGTX) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Cognition Therapeutics Announces $30.1M Direct Offering - MSN
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Short Interest Up 47.8% in August - MarketBeat
Analyst Upgrade: Will Cognition Therapeutics Inc outperform tech stocksMarket Activity Summary & Free Long-Term Investment Growth Plans - khodrobank.com
FOMO Trade: Is Cognition Therapeutics Inc a good stock for dollar cost averagingPortfolio Gains Report & Technical Pattern Recognition Alerts - خودرو بانک
Earnings Miss: Is Cognition Therapeutics Inc stock a top performer YTDWeekly Stock Report & Real-Time Stock Entry Alerts - خودرو بانک
Published on: 2025-09-19 07:05:54 - خودرو بانک
Loss Report: Is Cognition Therapeutics Inc stock a top performer YTDEarnings Beat & Capital Protection Trading Alerts - khodrobank.com
Technical Analysis: Is Axsome Therapeutics Inc gaining market share2025 Support & Resistance & Consistent Profit Trading Strategies - khodrobank.com
Cognition Therapeutics Inc Stock (CGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cognition Therapeutics Inc Stock (CGTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ricciardi Lisa | CEO & President |
Jan 31 '25 |
Buy |
0.77 |
38,851 |
30,001 |
38,851 |
2.05%
4.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):